COPD clinical trials in Dallas, TX
12 studies for COPD are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Recruiting
- University of Texas Southwestern, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- IntraCare- Site Number : 8400034, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RecruitingPhase 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
RecruitingPhase 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RecruitingPhase 2/3
- Alina Clinical Trials, LLC., Dallas
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RecruitingPhase 3
- Research Site, Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RecruitingPhase 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
RecruitingObservational study
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
RecruitingPhase 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
RecruitingObservational study
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RecruitingPhase 3
- GSK Investigational Site, Dallas
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA22 studies
- Miami, FL18 studies
- Birmingham, AL18 studies
- Boston, MA17 studies
- Houston, TX15 studies
- Orlando, FL15 studies
- Chicago, IL14 studies
- Baltimore, MD13 studies
- Pittsburgh, PA13 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
- Winston-Salem, NC9 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer52 studies
- Heart Failure43 studies
- Metastatic Cancer42 studies
- Cancer (all types)38 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity31 studies
- Ovarian Cancer28 studies
- Lung Cancer27 studies
- Bladder Cancer27 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.